Stryker, Johnson & Johnson and Zimmer Biomet posted their first quarter financial results for 2023, and data on their orthopedic sales.
Here is how they compare:
Total sales: $4.8 billion (+11.8 percent)
Orthopedics and spine: $2.1 billion (+12.7 percent)
Hips: $375 million (+14.4 percent)
Knees: $566 million (+22 percent)
Spine: $284 million (+1.9 percent)
Total sales: $24.7 billion (+5.6 percent)
Spine, sports and other: $699 million ( percent)
Orthopedic: $2.2 billion (+2.6percent)
Hips: $390 million (+0.4 percent)
Knees: $368 million (+8.7 percent)
Total sales: $1.8 billion (+10.1 percent)
Hips: $492.8 million (+9.3 percent)
Knees: $762.5 million (+15 percent)
Sports medicine, extremities, trauma, craniomaxillofacial and thoracic: $433.4 million (+4 percent)